Canon USA Invests in Spartan Bioscience | GenomeWeb

NEW YORK (GenomeWeb) – Canon USA said today that it has made a strategic investment in Canada's Spartan Bioscience to help fund the research and development of new diagnostic testing products.

Canon BioMedical, the recently established wholly owned subsidiary of Canon USA, plans to work with Spartan to develop future diagnostic products, including rapid genetic testing, Canon said.

Financial details of the investment were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.